Drug intelligence / Profile preview

paracetamol + pethidine

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Paracetamol + pethidine is a combination analgesic therapy consisting of two active ingredients: - **Paracetamol (also known as acetaminophen)** is a non-opioid analgesic and antipyretic that works primarily by inhibiting prostaglandin synthesis in the central nervous system, leading to reduced pain and fever. - **Pethidine (also known as meperidine)** is an opioid analgesic that acts mainly as an agonist at the mu-opioid receptor, altering pain perception and response in the central nervous system. Pethidine also has some anticholinergic properties and can inhibit dopamine and norepinephrine reuptake. This combination is used for short-term management of moderate to severe pain, particularly in postoperative settings such as after thyroid surgery or during labor. Clinical studies indicate that combining intravenous paracetamol with intramuscular pethidine provides superior pain control compared to paracetamol alone[4]. However, due to safety concerns associated with opioids—including risk of dependence, respiratory depression, neurotoxicity from metabolites like norpethidine (normeperidine), and other adverse effects—this combination is generally reserved for specific indications where alternative regimens are less effective[3][6][10].

Other names
acetaminophen + pethidineacetaminophen + meperidineparacetamol + meperidine
02

Targets

SCN10A (Sodium channel protein type X alpha subunit)SCN9A (Sodium channel protein type 9 subunit alpha)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on paracetamol + pethidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + pethidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call